Chlamydia pneumonae: A Treatable Cause of Atherosclerosis?

Antimicrobics and Infectious Diseases Newsletter

Volumn 16, Issue 1, 1997, Pages 1-4

  Muldowney III, James A S ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0040737377     PISSN: 1069417X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1069-417X(00)80011-4     Document Type: Article

References (17)

1. Blasi F, Denti F, Erba M, et al.: Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microb 34:2766-2769, 1996.
2. Buja LM: Does atherosclerosis have an infectious etiology? Circulation 94:872-873, 1996.
3. Capron L: Chlamydia in coronary plaques-hidden culprit or harmless hobo? Nat Med 2:856-857, 1996.
4. Fryert RH, Schwobe EP, Woods ML, Rodgers GM: Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. J Invest Med 45:168-174, 1997.
5. Grayston JT, Kuo C-C, Coulson AS, et al.: Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 92:3397-3400, 1995.
6. Kaukaranta-Tolvanen S-SE, Ronni T, Leinonen M, Saikku P, Laitinen K: Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae. Microb Pathogen 21:407-411, 1996.
7. Kuo C-C, Gown AM, Benditt EP, Grayston JT: Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunochemical stain. Arteriosclerosis & Thrombosis 13:1501-1504, 1993.
8. Kuo C-C, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT: Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 167:841-849, 1993.
9. Maseri A: Inflammation, atherosclerosis, and ischemic events - exploring the dark side of the moon. N Eng J Med 336:1014-1016, 1997.
10. Melnick SL, Shahlar E, Folsom AR, Grayston JT, Sorlie PD, Wang SP, Szklo M: Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Am J Med 95:499-504, 1993.
11. Ramirez JA: Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Int Med 96: 2766-2769, 1996.
12. Rasmussen SJ, Timms P, Beatty R, Stephens RS: Cytotoxic-T-lymphocyte-mediated cytolysis of L cells persistently infected with Chlamydia species. Infect Immun 64:1944-1949, 1996.
13. Saikku P, Leinonen M, Matrila K, et al.: Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet ii:983-985, 1988.
14. Saikku P, Leinonen M, Tenkanen L, et al.: Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Int Med 116:273-278, 1992.
15. Shor A, Kuo C-C, Patton DL: Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheroscleromatous plaques. S Africa Med J 82:158-160, 1992.
16. Thom DN, Wang SP, Grayston JT, et al.: Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterio Thromb 11:547-551, 1991.
17. Wimmer MLJ, Sandmann-Strupp R, Saikku P, Haberl RL: Association of chlamydial infection with cerebrovascular disease. Stroke 27:2207-2210, 1996.